Development of novel chitosan derivatives as micellar carriers of taxol. 1998

A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
Pharmaceutics Laboratory, Pharmaceutical Research Laboratories, Taisho Pharmaceutical Co., LTD, Saitama, Japan. s14831@ccm.taisho.co.jp

OBJECTIVE To develop an intravenous injectable carrier composed of chitosan derivatives for taxol. METHODS A chitosan with lauryl groups attached to amino groups to provide the hydrophobic moieties and, carboxymethyl groups attached to hydroxy groups to provide the hydrophilic moieties (N-lauryl-carboxymethyl-chitosan = LCC), was newly synthesized. The solubility of taxol in LCC micelles in aqueous solution was examined. The hemolysis test of LCC and the growth inhibition experiment of taxol-loading micelle using KB cells were also performed as in vitro assay. RESULTS It was found that LCC solubilized taxol by forming micelles with particle sizes less than 100nm. This particle size was considered effective for passive targeting for tumors. The concentration of taxol in the micellar solution was very high, with a maximum of 2.37mg/mL. This maximum was 1000 times above that in a saturated solution of taxol at pH 7.4. Hemolysis testing as an in vitro assay indicated that LCC was safer than Polysorbate 80 (TO-10M) as intravenous surfactant in terms of induction of membrane damage. As judged by cytostatic activity against KB cells, taxol retained activity even when included in LCC micelles. LCC-entrapped taxol was more effective in cytostatic activity than free taxol in low concentrations. CONCLUSIONS The results of solubilization capacity examination, hemolysis testing, and cytostatic activity suggest that LCC may be useful as a carrier of taxol.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007850 Lauric Acids 12-Carbon saturated monocarboxylic acids. Dodecanoic Acids,Acids, Dodecanoic,Acids, Lauric
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002686 Chitin A linear polysaccharide of beta-1->4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses

Related Publications

A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
January 2015, Current pharmaceutical design,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
February 2024, Pharmaceutics,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
May 2023, ACS biomaterials science & engineering,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
May 2010, Journal of medicinal chemistry,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
July 2020, Materials science & engineering. C, Materials for biological applications,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
January 2015, Journal of microencapsulation,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
August 2007, Pharmaceutical research,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
April 2018, Polymers,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
February 2023, International journal of molecular sciences,
A Miwa, and A Ishibe, and M Nakano, and T Yamahira, and S Itai, and S Jinno, and H Kawahara
December 2022, Carbohydrate research,
Copied contents to your clipboard!